SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
FOXA1
|
ENSG00000129514.4 | forkhead box A1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
FOXA1 | hg19_v2_chr14_-_38064198_38064239 | 0.59 | 5.9e-03 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr21_-_28215332 | 4.00 |
ENST00000517777.1
|
ADAMTS1
|
ADAM metallopeptidase with thrombospondin type 1 motif, 1 |
chr17_-_39684550 | 3.50 |
ENST00000455635.1
ENST00000361566.3 |
KRT19
|
keratin 19 |
chr3_+_189349162 | 3.06 |
ENST00000264731.3
ENST00000382063.4 ENST00000418709.2 ENST00000320472.5 ENST00000392460.3 ENST00000440651.2 |
TP63
|
tumor protein p63 |
chrX_+_135614293 | 3.00 |
ENST00000370634.3
|
VGLL1
|
vestigial like 1 (Drosophila) |
chr1_+_35225339 | 2.92 |
ENST00000339480.1
|
GJB4
|
gap junction protein, beta 4, 30.3kDa |
chr1_-_1356628 | 2.92 |
ENST00000442470.1
ENST00000537107.1 |
ANKRD65
|
ankyrin repeat domain 65 |
chr12_-_89746173 | 2.89 |
ENST00000308385.6
|
DUSP6
|
dual specificity phosphatase 6 |
chr13_+_78109804 | 2.81 |
ENST00000535157.1
|
SCEL
|
sciellin |
chr13_+_78109884 | 2.81 |
ENST00000377246.3
ENST00000349847.3 |
SCEL
|
sciellin |
chr1_-_1356719 | 2.79 |
ENST00000520296.1
|
ANKRD65
|
ankyrin repeat domain 65 |
chr10_+_51549498 | 2.65 |
ENST00000358559.2
ENST00000298239.6 |
MSMB
|
microseminoprotein, beta- |
chr17_-_46035187 | 2.55 |
ENST00000300557.2
|
PRR15L
|
proline rich 15-like |
chr1_+_152486950 | 2.45 |
ENST00000368790.3
|
CRCT1
|
cysteine-rich C-terminal 1 |
chr11_-_124622134 | 2.43 |
ENST00000326621.5
|
VSIG2
|
V-set and immunoglobulin domain containing 2 |
chr13_-_86373536 | 2.16 |
ENST00000400286.2
|
SLITRK6
|
SLIT and NTRK-like family, member 6 |
chr11_-_124622083 | 2.06 |
ENST00000403470.1
|
VSIG2
|
V-set and immunoglobulin domain containing 2 |
chr1_-_111743285 | 2.05 |
ENST00000357640.4
|
DENND2D
|
DENN/MADD domain containing 2D |
chr14_-_21493884 | 2.01 |
ENST00000556974.1
ENST00000554419.1 ENST00000298687.5 ENST00000397858.1 ENST00000360463.3 ENST00000350792.3 ENST00000397847.2 |
NDRG2
|
NDRG family member 2 |
chr2_-_214016314 | 2.00 |
ENST00000434687.1
ENST00000374319.4 |
IKZF2
|
IKAROS family zinc finger 2 (Helios) |
chr14_-_36988882 | 1.98 |
ENST00000498187.2
|
NKX2-1
|
NK2 homeobox 1 |
chr17_+_38333263 | 1.96 |
ENST00000456989.2
ENST00000543876.1 ENST00000544503.1 ENST00000264644.6 ENST00000538884.1 |
RAPGEFL1
|
Rap guanine nucleotide exchange factor (GEF)-like 1 |
chr1_+_24646002 | 1.91 |
ENST00000356046.2
|
GRHL3
|
grainyhead-like 3 (Drosophila) |
chr19_-_45909585 | 1.90 |
ENST00000593226.1
ENST00000418234.2 |
PPP1R13L
|
protein phosphatase 1, regulatory subunit 13 like |
chr12_-_54778471 | 1.88 |
ENST00000550120.1
ENST00000394313.2 ENST00000547210.1 |
ZNF385A
|
zinc finger protein 385A |
chr15_+_101417919 | 1.88 |
ENST00000561338.1
|
ALDH1A3
|
aldehyde dehydrogenase 1 family, member A3 |
chr1_+_24645865 | 1.87 |
ENST00000342072.4
|
GRHL3
|
grainyhead-like 3 (Drosophila) |
chr15_+_96869165 | 1.87 |
ENST00000421109.2
|
NR2F2
|
nuclear receptor subfamily 2, group F, member 2 |
chr1_+_24645807 | 1.84 |
ENST00000361548.4
|
GRHL3
|
grainyhead-like 3 (Drosophila) |
chr14_-_21493649 | 1.84 |
ENST00000553442.1
ENST00000555869.1 ENST00000556457.1 ENST00000397844.2 ENST00000554415.1 |
NDRG2
|
NDRG family member 2 |
chr3_-_185538849 | 1.77 |
ENST00000421047.2
|
IGF2BP2
|
insulin-like growth factor 2 mRNA binding protein 2 |
chr17_+_74372662 | 1.73 |
ENST00000591651.1
ENST00000545180.1 |
SPHK1
|
sphingosine kinase 1 |
chr5_+_125800836 | 1.69 |
ENST00000511134.1
|
GRAMD3
|
GRAM domain containing 3 |
chr7_+_73242490 | 1.67 |
ENST00000431918.1
|
CLDN4
|
claudin 4 |
chr5_+_102201509 | 1.63 |
ENST00000348126.2
ENST00000379787.4 |
PAM
|
peptidylglycine alpha-amidating monooxygenase |
chr12_-_54778244 | 1.62 |
ENST00000549937.1
|
ZNF385A
|
zinc finger protein 385A |
chr12_-_54778444 | 1.56 |
ENST00000551771.1
|
ZNF385A
|
zinc finger protein 385A |
chr1_+_24645915 | 1.54 |
ENST00000350501.5
|
GRHL3
|
grainyhead-like 3 (Drosophila) |
chr4_-_74486347 | 1.50 |
ENST00000342081.3
|
RASSF6
|
Ras association (RalGDS/AF-6) domain family member 6 |
chr2_-_220042825 | 1.43 |
ENST00000409789.1
|
CNPPD1
|
cyclin Pas1/PHO80 domain containing 1 |
chr1_+_24646263 | 1.42 |
ENST00000524724.1
|
GRHL3
|
grainyhead-like 3 (Drosophila) |
chr12_-_89746264 | 1.40 |
ENST00000548755.1
|
DUSP6
|
dual specificity phosphatase 6 |
chr11_+_62186498 | 1.38 |
ENST00000278282.2
|
SCGB1A1
|
secretoglobin, family 1A, member 1 (uteroglobin) |
chr14_+_37126765 | 1.36 |
ENST00000402703.2
|
PAX9
|
paired box 9 |
chr1_+_220701456 | 1.35 |
ENST00000366918.4
ENST00000402574.1 |
MARK1
|
MAP/microtubule affinity-regulating kinase 1 |
chr5_+_102201430 | 1.35 |
ENST00000438793.3
ENST00000346918.2 |
PAM
|
peptidylglycine alpha-amidating monooxygenase |
chr1_+_174933899 | 1.35 |
ENST00000367688.3
|
RABGAP1L
|
RAB GTPase activating protein 1-like |
chr4_+_75174180 | 1.33 |
ENST00000413830.1
|
EPGN
|
epithelial mitogen |
chrX_-_30885319 | 1.30 |
ENST00000378933.1
|
TAB3
|
TGF-beta activated kinase 1/MAP3K7 binding protein 3 |
chr20_+_31823792 | 1.25 |
ENST00000375413.4
ENST00000354297.4 ENST00000375422.2 |
BPIFA1
|
BPI fold containing family A, member 1 |
chr8_+_120079478 | 1.23 |
ENST00000332843.2
|
COLEC10
|
collectin sub-family member 10 (C-type lectin) |
chr4_-_74486109 | 1.21 |
ENST00000395777.2
|
RASSF6
|
Ras association (RalGDS/AF-6) domain family member 6 |
chr20_-_45984401 | 1.19 |
ENST00000311275.7
|
ZMYND8
|
zinc finger, MYND-type containing 8 |
chr1_+_12538594 | 1.14 |
ENST00000543710.1
|
VPS13D
|
vacuolar protein sorting 13 homolog D (S. cerevisiae) |
chr3_+_160394940 | 1.12 |
ENST00000320767.2
|
ARL14
|
ADP-ribosylation factor-like 14 |
chr5_+_40841276 | 1.09 |
ENST00000254691.5
|
CARD6
|
caspase recruitment domain family, member 6 |
chr4_+_26321284 | 1.04 |
ENST00000506956.1
ENST00000512671.1 ENST00000345843.3 ENST00000342295.1 |
RBPJ
|
recombination signal binding protein for immunoglobulin kappa J region |
chr9_-_89562104 | 1.03 |
ENST00000298743.7
|
GAS1
|
growth arrest-specific 1 |
chr1_-_177939041 | 1.03 |
ENST00000308284.6
|
SEC16B
|
SEC16 homolog B (S. cerevisiae) |
chr1_+_61547894 | 1.00 |
ENST00000403491.3
|
NFIA
|
nuclear factor I/A |
chr5_+_40841410 | 0.99 |
ENST00000381677.3
|
CARD6
|
caspase recruitment domain family, member 6 |
chr12_-_52828147 | 0.98 |
ENST00000252245.5
|
KRT75
|
keratin 75 |
chr6_+_7107999 | 0.98 |
ENST00000491191.1
ENST00000379938.2 ENST00000471433.1 |
RREB1
|
ras responsive element binding protein 1 |
chr5_+_125706998 | 0.97 |
ENST00000506445.1
|
GRAMD3
|
GRAM domain containing 3 |
chr14_-_38064198 | 0.97 |
ENST00000250448.2
|
FOXA1
|
forkhead box A1 |
chr5_-_115872124 | 0.96 |
ENST00000515009.1
|
SEMA6A
|
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A |
chr4_+_75174204 | 0.95 |
ENST00000332112.4
ENST00000514968.1 ENST00000503098.1 ENST00000502358.1 ENST00000509145.1 ENST00000505212.1 |
EPGN
|
epithelial mitogen |
chr20_-_52687059 | 0.92 |
ENST00000371435.2
ENST00000395961.3 |
BCAS1
|
breast carcinoma amplified sequence 1 |
chr1_-_115300579 | 0.91 |
ENST00000358528.4
ENST00000525132.1 |
CSDE1
|
cold shock domain containing E1, RNA-binding |
chr13_-_46716969 | 0.91 |
ENST00000435666.2
|
LCP1
|
lymphocyte cytosolic protein 1 (L-plastin) |
chrX_-_15619076 | 0.87 |
ENST00000252519.3
|
ACE2
|
angiotensin I converting enzyme 2 |
chr5_-_115872142 | 0.87 |
ENST00000510263.1
|
SEMA6A
|
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A |
chr10_+_99400443 | 0.87 |
ENST00000370631.3
|
PI4K2A
|
phosphatidylinositol 4-kinase type 2 alpha |
chr1_-_115300592 | 0.87 |
ENST00000261443.5
ENST00000534699.1 ENST00000339438.6 ENST00000529046.1 ENST00000525970.1 ENST00000369530.1 ENST00000530886.1 |
CSDE1
|
cold shock domain containing E1, RNA-binding |
chr6_+_26251835 | 0.86 |
ENST00000356350.2
|
HIST1H2BH
|
histone cluster 1, H2bh |
chr14_+_37131058 | 0.85 |
ENST00000361487.6
|
PAX9
|
paired box 9 |
chr10_+_24738355 | 0.85 |
ENST00000307544.6
|
KIAA1217
|
KIAA1217 |
chr6_+_47666275 | 0.85 |
ENST00000327753.3
ENST00000283303.2 |
GPR115
|
G protein-coupled receptor 115 |
chr4_-_87028478 | 0.85 |
ENST00000515400.1
ENST00000395157.3 |
MAPK10
|
mitogen-activated protein kinase 10 |
chr6_-_43596899 | 0.83 |
ENST00000307126.5
ENST00000452781.1 |
GTPBP2
|
GTP binding protein 2 |
chr1_-_11107280 | 0.82 |
ENST00000400897.3
ENST00000400898.3 |
MASP2
|
mannan-binding lectin serine peptidase 2 |
chrX_+_37865804 | 0.82 |
ENST00000297875.2
ENST00000357972.5 |
SYTL5
|
synaptotagmin-like 5 |
chr5_+_150157860 | 0.82 |
ENST00000600109.1
|
AC010441.1
|
AC010441.1 |
chr3_-_105588231 | 0.81 |
ENST00000545639.1
ENST00000394027.3 ENST00000438603.1 ENST00000447441.1 ENST00000443752.1 |
CBLB
|
Cbl proto-oncogene B, E3 ubiquitin protein ligase |
chr6_+_7108210 | 0.81 |
ENST00000467782.1
ENST00000334984.6 ENST00000349384.6 |
RREB1
|
ras responsive element binding protein 1 |
chr20_+_52105495 | 0.80 |
ENST00000439873.2
|
AL354993.1
|
Cell growth-inhibiting protein 7; HCG1784586; Uncharacterized protein |
chr14_-_36983034 | 0.77 |
ENST00000518529.2
|
SFTA3
|
surfactant associated 3 |
chr7_-_84121858 | 0.76 |
ENST00000448879.1
|
SEMA3A
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A |
chr6_-_56707943 | 0.76 |
ENST00000370769.4
ENST00000421834.2 ENST00000312431.6 ENST00000361203.3 ENST00000523817.1 |
DST
|
dystonin |
chr17_+_8924837 | 0.75 |
ENST00000173229.2
|
NTN1
|
netrin 1 |
chr5_+_150157444 | 0.74 |
ENST00000526627.1
|
SMIM3
|
small integral membrane protein 3 |
chr20_-_7921090 | 0.73 |
ENST00000378789.3
|
HAO1
|
hydroxyacid oxidase (glycolate oxidase) 1 |
chr5_-_142065612 | 0.73 |
ENST00000360966.5
ENST00000411960.1 |
FGF1
|
fibroblast growth factor 1 (acidic) |
chr21_+_17791648 | 0.73 |
ENST00000602892.1
ENST00000418813.2 ENST00000435697.1 |
LINC00478
|
long intergenic non-protein coding RNA 478 |
chr10_-_75676400 | 0.73 |
ENST00000412307.2
|
C10orf55
|
chromosome 10 open reading frame 55 |
chr11_-_108464321 | 0.72 |
ENST00000265843.4
|
EXPH5
|
exophilin 5 |
chr8_-_116681221 | 0.72 |
ENST00000395715.3
|
TRPS1
|
trichorhinophalangeal syndrome I |
chr19_+_18492973 | 0.71 |
ENST00000595973.2
|
GDF15
|
growth differentiation factor 15 |
chr19_-_15443318 | 0.71 |
ENST00000360016.5
|
BRD4
|
bromodomain containing 4 |
chr3_-_71294304 | 0.70 |
ENST00000498215.1
|
FOXP1
|
forkhead box P1 |
chr1_-_57431679 | 0.69 |
ENST00000371237.4
ENST00000535057.1 ENST00000543257.1 |
C8B
|
complement component 8, beta polypeptide |
chr7_+_134430212 | 0.68 |
ENST00000436461.2
|
CALD1
|
caldesmon 1 |
chr17_-_48546324 | 0.66 |
ENST00000508540.1
|
CHAD
|
chondroadherin |
chr1_+_116654376 | 0.65 |
ENST00000369500.3
|
MAB21L3
|
mab-21-like 3 (C. elegans) |
chr12_+_40787194 | 0.65 |
ENST00000425730.2
ENST00000454784.4 |
MUC19
|
mucin 19, oligomeric |
chr8_-_116681123 | 0.65 |
ENST00000519674.1
|
TRPS1
|
trichorhinophalangeal syndrome I |
chr2_+_171640291 | 0.64 |
ENST00000409885.1
|
ERICH2
|
glutamate-rich 2 |
chr1_+_40810516 | 0.64 |
ENST00000435168.2
|
SMAP2
|
small ArfGAP2 |
chr10_+_102891048 | 0.63 |
ENST00000467928.2
|
TLX1
|
T-cell leukemia homeobox 1 |
chr1_-_177939348 | 0.63 |
ENST00000464631.2
|
SEC16B
|
SEC16 homolog B (S. cerevisiae) |
chr19_-_18902106 | 0.62 |
ENST00000542601.2
ENST00000425807.1 ENST00000222271.2 |
COMP
|
cartilage oligomeric matrix protein |
chr5_+_179921344 | 0.62 |
ENST00000261951.4
|
CNOT6
|
CCR4-NOT transcription complex, subunit 6 |
chr1_+_104159999 | 0.61 |
ENST00000414303.2
ENST00000423678.1 |
AMY2A
|
amylase, alpha 2A (pancreatic) |
chr17_-_48546232 | 0.61 |
ENST00000258969.4
|
CHAD
|
chondroadherin |
chr11_-_108464465 | 0.60 |
ENST00000525344.1
|
EXPH5
|
exophilin 5 |
chr5_+_179921430 | 0.60 |
ENST00000393356.1
|
CNOT6
|
CCR4-NOT transcription complex, subunit 6 |
chr4_+_165675197 | 0.60 |
ENST00000515485.1
|
RP11-294O2.2
|
RP11-294O2.2 |
chr12_+_27849378 | 0.59 |
ENST00000310791.2
|
REP15
|
RAB15 effector protein |
chr2_+_150187020 | 0.59 |
ENST00000334166.4
|
LYPD6
|
LY6/PLAUR domain containing 6 |
chr21_-_40033618 | 0.58 |
ENST00000417133.2
ENST00000398910.1 ENST00000442448.1 |
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog |
chr4_-_140544386 | 0.58 |
ENST00000561977.1
|
RP11-308D13.3
|
RP11-308D13.3 |
chr14_+_23654525 | 0.57 |
ENST00000399910.1
ENST00000492621.1 |
C14orf164
|
chromosome 14 open reading frame 164 |
chr12_+_10365404 | 0.57 |
ENST00000266458.5
ENST00000421801.2 ENST00000544284.1 ENST00000545047.1 ENST00000543602.1 ENST00000545887.1 |
GABARAPL1
|
GABA(A) receptor-associated protein like 1 |
chrX_-_24665353 | 0.56 |
ENST00000379144.2
|
PCYT1B
|
phosphate cytidylyltransferase 1, choline, beta |
chr2_-_172017393 | 0.56 |
ENST00000442919.2
|
TLK1
|
tousled-like kinase 1 |
chrX_+_22050546 | 0.53 |
ENST00000379374.4
|
PHEX
|
phosphate regulating endopeptidase homolog, X-linked |
chr1_+_61547405 | 0.52 |
ENST00000371189.4
|
NFIA
|
nuclear factor I/A |
chr7_+_107384142 | 0.52 |
ENST00000440859.3
|
CBLL1
|
Cbl proto-oncogene-like 1, E3 ubiquitin protein ligase |
chr1_+_43855545 | 0.52 |
ENST00000372450.4
ENST00000310739.4 |
SZT2
|
seizure threshold 2 homolog (mouse) |
chr3_-_71632894 | 0.49 |
ENST00000493089.1
|
FOXP1
|
forkhead box P1 |
chr3_+_174577070 | 0.49 |
ENST00000454872.1
|
NAALADL2
|
N-acetylated alpha-linked acidic dipeptidase-like 2 |
chr7_+_134576317 | 0.48 |
ENST00000424922.1
ENST00000495522.1 |
CALD1
|
caldesmon 1 |
chr17_-_39140549 | 0.48 |
ENST00000377755.4
|
KRT40
|
keratin 40 |
chr6_+_7107830 | 0.48 |
ENST00000379933.3
|
RREB1
|
ras responsive element binding protein 1 |
chr8_+_11666649 | 0.48 |
ENST00000528643.1
ENST00000525777.1 |
FDFT1
|
farnesyl-diphosphate farnesyltransferase 1 |
chrX_-_48815633 | 0.48 |
ENST00000428668.2
|
OTUD5
|
OTU domain containing 5 |
chr8_-_116673894 | 0.47 |
ENST00000395713.2
|
TRPS1
|
trichorhinophalangeal syndrome I |
chrX_-_24665208 | 0.45 |
ENST00000356768.4
|
PCYT1B
|
phosphate cytidylyltransferase 1, choline, beta |
chr2_-_207078086 | 0.45 |
ENST00000442134.1
|
GPR1
|
G protein-coupled receptor 1 |
chr5_+_95998746 | 0.45 |
ENST00000508608.1
|
CAST
|
calpastatin |
chr1_+_35734562 | 0.44 |
ENST00000314607.6
ENST00000373297.2 |
ZMYM4
|
zinc finger, MYM-type 4 |
chr19_-_49118067 | 0.43 |
ENST00000593772.1
|
FAM83E
|
family with sequence similarity 83, member E |
chr6_+_74405804 | 0.43 |
ENST00000287097.5
|
CD109
|
CD109 molecule |
chr3_-_193272741 | 0.43 |
ENST00000392443.3
|
ATP13A4
|
ATPase type 13A4 |
chr12_+_10658489 | 0.42 |
ENST00000538173.1
|
EIF2S3L
|
Putative eukaryotic translation initiation factor 2 subunit 3-like protein |
chr2_-_87248975 | 0.42 |
ENST00000409310.2
ENST00000355705.3 |
PLGLB1
|
plasminogen-like B1 |
chrX_+_47863734 | 0.42 |
ENST00000304355.5
|
SPACA5
|
sperm acrosome associated 5 |
chr2_-_172017343 | 0.41 |
ENST00000431350.2
ENST00000360843.3 |
TLK1
|
tousled-like kinase 1 |
chr12_-_78934441 | 0.41 |
ENST00000546865.1
ENST00000547089.1 |
RP11-171L9.1
|
RP11-171L9.1 |
chr6_+_135502408 | 0.40 |
ENST00000341911.5
ENST00000442647.2 ENST00000316528.8 |
MYB
|
v-myb avian myeloblastosis viral oncogene homolog |
chr21_-_43735446 | 0.40 |
ENST00000398431.2
|
TFF3
|
trefoil factor 3 (intestinal) |
chr1_-_203320617 | 0.40 |
ENST00000354955.4
|
FMOD
|
fibromodulin |
chr6_+_88054530 | 0.40 |
ENST00000388923.4
|
C6orf163
|
chromosome 6 open reading frame 163 |
chr2_+_58655461 | 0.39 |
ENST00000429095.1
ENST00000429664.1 ENST00000452840.1 |
AC007092.1
|
long intergenic non-protein coding RNA 1122 |
chr21_+_17791838 | 0.39 |
ENST00000453910.1
|
LINC00478
|
long intergenic non-protein coding RNA 478 |
chr13_-_49975632 | 0.37 |
ENST00000457041.1
ENST00000355854.4 |
CAB39L
|
calcium binding protein 39-like |
chr4_-_103940791 | 0.37 |
ENST00000510559.1
ENST00000394789.3 ENST00000296422.7 |
SLC9B1
|
solute carrier family 9, subfamily B (NHA1, cation proton antiporter 1), member 1 |
chr17_+_72931876 | 0.37 |
ENST00000328801.4
|
OTOP3
|
otopetrin 3 |
chr6_+_33589161 | 0.37 |
ENST00000605930.1
|
ITPR3
|
inositol 1,4,5-trisphosphate receptor, type 3 |
chr21_-_31588338 | 0.37 |
ENST00000286809.1
|
CLDN8
|
claudin 8 |
chr4_+_56719782 | 0.37 |
ENST00000381295.2
ENST00000346134.7 ENST00000349598.6 |
EXOC1
|
exocyst complex component 1 |
chr10_-_90751038 | 0.36 |
ENST00000458159.1
ENST00000415557.1 ENST00000458208.1 |
ACTA2
|
actin, alpha 2, smooth muscle, aorta |
chr6_-_117747015 | 0.36 |
ENST00000368508.3
ENST00000368507.3 |
ROS1
|
c-ros oncogene 1 , receptor tyrosine kinase |
chr6_+_135502466 | 0.35 |
ENST00000367814.4
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog |
chr2_+_238877424 | 0.35 |
ENST00000434655.1
|
UBE2F
|
ubiquitin-conjugating enzyme E2F (putative) |
chr8_+_12809531 | 0.34 |
ENST00000532376.2
|
KIAA1456
|
KIAA1456 |
chr2_-_102091144 | 0.34 |
ENST00000428343.1
|
RFX8
|
RFX family member 8, lacking RFX DNA binding domain |
chr1_+_145883868 | 0.34 |
ENST00000447947.2
|
GPR89C
|
G protein-coupled receptor 89C |
chr21_-_31588365 | 0.34 |
ENST00000399899.1
|
CLDN8
|
claudin 8 |
chr19_-_50380536 | 0.34 |
ENST00000391832.3
ENST00000391834.2 ENST00000344175.5 |
AKT1S1
|
AKT1 substrate 1 (proline-rich) |
chr12_+_96588143 | 0.34 |
ENST00000228741.3
ENST00000547249.1 |
ELK3
|
ELK3, ETS-domain protein (SRF accessory protein 2) |
chr20_+_31755934 | 0.33 |
ENST00000354932.5
|
BPIFA2
|
BPI fold containing family A, member 2 |
chr22_-_17700260 | 0.33 |
ENST00000399837.2
ENST00000543038.1 |
CECR1
|
cat eye syndrome chromosome region, candidate 1 |
chr6_+_74405501 | 0.33 |
ENST00000437994.2
ENST00000422508.2 |
CD109
|
CD109 molecule |
chr20_-_55841398 | 0.33 |
ENST00000395864.3
|
BMP7
|
bone morphogenetic protein 7 |
chr1_+_204839959 | 0.32 |
ENST00000404076.1
|
NFASC
|
neurofascin |
chr20_-_43150601 | 0.32 |
ENST00000541235.1
ENST00000255175.1 ENST00000342374.4 |
SERINC3
|
serine incorporator 3 |
chr3_+_52245458 | 0.30 |
ENST00000459884.1
|
ALAS1
|
aminolevulinate, delta-, synthase 1 |
chr10_-_81708854 | 0.30 |
ENST00000372292.3
|
SFTPD
|
surfactant protein D |
chr12_-_92536433 | 0.29 |
ENST00000551563.2
ENST00000546975.1 ENST00000549802.1 |
C12orf79
|
chromosome 12 open reading frame 79 |
chr3_+_186692745 | 0.29 |
ENST00000438590.1
|
ST6GAL1
|
ST6 beta-galactosamide alpha-2,6-sialyltranferase 1 |
chr4_+_86396265 | 0.29 |
ENST00000395184.1
|
ARHGAP24
|
Rho GTPase activating protein 24 |
chr2_-_182545603 | 0.29 |
ENST00000295108.3
|
NEUROD1
|
neuronal differentiation 1 |
chr13_+_76334795 | 0.28 |
ENST00000526202.1
ENST00000465261.2 |
LMO7
|
LIM domain 7 |
chr18_-_53070913 | 0.28 |
ENST00000568186.1
ENST00000564228.1 |
TCF4
|
transcription factor 4 |
chr11_-_119247004 | 0.28 |
ENST00000531070.1
|
USP2
|
ubiquitin specific peptidase 2 |
chr11_+_66025938 | 0.28 |
ENST00000394066.2
|
KLC2
|
kinesin light chain 2 |
chr2_+_105050794 | 0.27 |
ENST00000429464.1
ENST00000414442.1 ENST00000447380.1 |
AC013402.2
|
long intergenic non-protein coding RNA 1102 |
chr6_+_101847105 | 0.26 |
ENST00000369137.3
ENST00000318991.6 |
GRIK2
|
glutamate receptor, ionotropic, kainate 2 |
chr2_-_121223697 | 0.26 |
ENST00000593290.1
|
FLJ14816
|
long intergenic non-protein coding RNA 1101 |
chr7_+_129906660 | 0.26 |
ENST00000222481.4
|
CPA2
|
carboxypeptidase A2 (pancreatic) |
chr5_+_74011328 | 0.25 |
ENST00000513336.1
|
HEXB
|
hexosaminidase B (beta polypeptide) |
chr2_+_103089756 | 0.25 |
ENST00000295269.4
|
SLC9A4
|
solute carrier family 9, subfamily A (NHE4, cation proton antiporter 4), member 4 |
chr6_+_135502501 | 0.25 |
ENST00000527615.1
ENST00000420123.2 ENST00000525369.1 ENST00000528774.1 ENST00000534121.1 ENST00000534044.1 ENST00000533624.1 |
MYB
|
v-myb avian myeloblastosis viral oncogene homolog |
chr9_+_136287444 | 0.25 |
ENST00000355699.2
ENST00000356589.2 ENST00000371911.3 |
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13 |
chr22_+_21128167 | 0.24 |
ENST00000215727.5
|
SERPIND1
|
serpin peptidase inhibitor, clade D (heparin cofactor), member 1 |
chr16_-_4896205 | 0.24 |
ENST00000589389.1
|
GLYR1
|
glyoxylate reductase 1 homolog (Arabidopsis) |
chr19_-_48894104 | 0.24 |
ENST00000597017.1
|
KDELR1
|
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 1 |
chrX_-_48814810 | 0.24 |
ENST00000376488.3
ENST00000396743.3 ENST00000156084.4 |
OTUD5
|
OTU domain containing 5 |
chr12_-_66275350 | 0.23 |
ENST00000536648.1
|
RP11-366L20.2
|
Uncharacterized protein |
chr2_+_58655520 | 0.23 |
ENST00000455219.3
ENST00000449448.2 |
AC007092.1
|
long intergenic non-protein coding RNA 1122 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 4.3 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
0.8 | 3.1 | GO:0007499 | ectoderm and mesoderm interaction(GO:0007499) |
0.7 | 5.1 | GO:1902162 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
0.6 | 1.7 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
0.6 | 2.3 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.5 | 1.9 | GO:0060166 | olfactory pit development(GO:0060166) |
0.5 | 1.9 | GO:0009956 | radial pattern formation(GO:0009956) |
0.4 | 2.3 | GO:0018032 | protein amidation(GO:0018032) |
0.4 | 2.2 | GO:0060005 | vestibular reflex(GO:0060005) |
0.4 | 8.6 | GO:0090179 | planar cell polarity pathway involved in neural tube closure(GO:0090179) |
0.3 | 2.4 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.3 | 1.0 | GO:1990922 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
0.3 | 1.0 | GO:0060738 | epithelial-mesenchymal signaling involved in prostate gland development(GO:0060738) |
0.3 | 1.3 | GO:1900154 | regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
0.3 | 1.2 | GO:1900190 | biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
0.3 | 0.9 | GO:0003051 | angiotensin-mediated drinking behavior(GO:0003051) |
0.3 | 0.9 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
0.2 | 1.0 | GO:1903045 | neural crest cell migration involved in sympathetic nervous system development(GO:1903045) |
0.2 | 1.4 | GO:0010193 | response to ozone(GO:0010193) |
0.2 | 2.9 | GO:0042048 | olfactory behavior(GO:0042048) |
0.2 | 3.8 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.2 | 4.1 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.2 | 1.2 | GO:0032625 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
0.2 | 2.1 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.2 | 2.0 | GO:0021759 | globus pallidus development(GO:0021759) |
0.1 | 0.7 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.1 | 0.4 | GO:1905069 | allantois development(GO:1905069) |
0.1 | 1.2 | GO:1902952 | positive regulation of dendritic spine maintenance(GO:1902952) regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
0.1 | 1.0 | GO:1905066 | positive regulation of ephrin receptor signaling pathway(GO:1901189) regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901295) positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901297) regulation of canonical Wnt signaling pathway involved in heart development(GO:1905066) positive regulation of canonical Wnt signaling pathway involved in heart development(GO:1905068) |
0.1 | 2.3 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.1 | 0.8 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.1 | 0.7 | GO:0009441 | glycolate metabolic process(GO:0009441) |
0.1 | 0.6 | GO:0044245 | polysaccharide digestion(GO:0044245) |
0.1 | 0.3 | GO:0060730 | regulation of intestinal epithelial structure maintenance(GO:0060730) |
0.1 | 0.5 | GO:0008204 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
0.1 | 0.8 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.1 | 0.4 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 0.4 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.1 | 0.5 | GO:1904383 | response to sodium phosphate(GO:1904383) |
0.1 | 1.8 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.1 | 1.0 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.1 | 0.6 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.1 | 1.7 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.1 | 1.0 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.1 | 0.7 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.1 | 0.4 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.1 | 1.5 | GO:0072189 | ureter development(GO:0072189) |
0.1 | 1.7 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.1 | 1.0 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.1 | 0.4 | GO:0090131 | mesenchyme migration(GO:0090131) |
0.1 | 0.8 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.1 | 0.8 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 2.2 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.1 | 1.9 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.1 | 0.2 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
0.1 | 0.6 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.1 | 2.7 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 1.3 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.2 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.0 | 0.3 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.0 | 0.3 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.0 | 0.8 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.0 | 0.7 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
0.0 | 0.3 | GO:0060179 | male mating behavior(GO:0060179) |
0.0 | 0.9 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.0 | 0.2 | GO:0002304 | gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
0.0 | 0.3 | GO:0097056 | selenocysteinyl-tRNA(Sec) biosynthetic process(GO:0097056) |
0.0 | 0.2 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
0.0 | 0.3 | GO:0009597 | detection of virus(GO:0009597) |
0.0 | 0.4 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.0 | 0.3 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.0 | 0.2 | GO:0008218 | bioluminescence(GO:0008218) |
0.0 | 0.2 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) type B pancreatic cell maturation(GO:0072560) |
0.0 | 0.7 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.4 | GO:0035826 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
0.0 | 0.1 | GO:0099553 | trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
0.0 | 0.1 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.0 | 0.6 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.0 | 0.3 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.0 | 0.2 | GO:0010265 | SCF complex assembly(GO:0010265) |
0.0 | 0.1 | GO:0014028 | notochord formation(GO:0014028) |
0.0 | 0.5 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
0.0 | 0.2 | GO:0035864 | response to potassium ion(GO:0035864) |
0.0 | 0.3 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
0.0 | 6.4 | GO:0030216 | keratinocyte differentiation(GO:0030216) |
0.0 | 0.3 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.0 | 0.7 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.0 | 0.2 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.0 | 1.4 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.0 | 0.2 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.0 | 0.4 | GO:0051601 | exocyst localization(GO:0051601) |
0.0 | 0.1 | GO:0007412 | axon target recognition(GO:0007412) |
0.0 | 0.5 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.3 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.0 | 0.1 | GO:0002870 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
0.0 | 0.2 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.4 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.3 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.0 | 0.1 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
0.0 | 0.2 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.0 | 0.1 | GO:0060174 | limb bud formation(GO:0060174) |
0.0 | 0.1 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.0 | 0.7 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.0 | 0.2 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.0 | 0.2 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.6 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.0 | 0.2 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.0 | 0.1 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
0.0 | 0.2 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.0 | 0.3 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.0 | 0.2 | GO:0046330 | positive regulation of JNK cascade(GO:0046330) |
0.0 | 0.0 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 1.4 | GO:1990357 | terminal web(GO:1990357) |
0.2 | 0.9 | GO:0035838 | growing cell tip(GO:0035838) |
0.1 | 0.8 | GO:0031673 | H zone(GO:0031673) |
0.1 | 2.9 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 0.3 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.1 | 1.0 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 0.7 | GO:1990130 | Iml1 complex(GO:1990130) |
0.1 | 1.4 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 0.4 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.1 | 0.7 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 1.2 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 5.6 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 0.4 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.1 | 0.3 | GO:0016938 | kinesin I complex(GO:0016938) |
0.0 | 0.3 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.0 | 1.2 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.0 | 1.8 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 0.9 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 1.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 4.7 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.8 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 3.6 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 1.9 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 0.4 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.0 | 0.2 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.0 | 1.0 | GO:0016363 | nuclear matrix(GO:0016363) |
0.0 | 0.3 | GO:0031931 | TORC1 complex(GO:0031931) |
0.0 | 1.0 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.6 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.0 | 0.1 | GO:0031905 | early endosome lumen(GO:0031905) |
0.0 | 1.1 | GO:0000786 | nucleosome(GO:0000786) |
0.0 | 0.1 | GO:0016013 | syntrophin complex(GO:0016013) |
0.0 | 1.2 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 3.2 | GO:0001650 | fibrillar center(GO:0001650) |
0.0 | 0.4 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.0 | 0.8 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 0.2 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
0.0 | 0.7 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 2.3 | GO:0004598 | peptidylglycine monooxygenase activity(GO:0004504) peptidylamidoglycolate lyase activity(GO:0004598) |
0.2 | 1.7 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.2 | 0.7 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.2 | 0.9 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.2 | 4.0 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.2 | 0.8 | GO:0001855 | complement component C4b binding(GO:0001855) |
0.2 | 1.0 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.2 | 3.1 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.1 | 0.6 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.1 | 1.9 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 1.4 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.1 | 0.6 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.1 | 0.5 | GO:0051996 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
0.1 | 0.9 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.1 | 0.3 | GO:0016749 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
0.1 | 0.4 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.1 | 0.8 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.1 | 1.5 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.1 | 1.0 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 0.2 | GO:1902271 | D3 vitamins binding(GO:1902271) |
0.1 | 1.2 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.2 | GO:0005046 | KDEL sequence binding(GO:0005046) |
0.1 | 0.7 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.1 | 8.5 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.1 | 1.0 | GO:0000150 | recombinase activity(GO:0000150) |
0.1 | 1.4 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 5.8 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 0.4 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.0 | 0.2 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 1.2 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.0 | 1.0 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 1.9 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 0.3 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.0 | 1.4 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 1.8 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 0.2 | GO:0004031 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.0 | 0.4 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.4 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.0 | 4.2 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.3 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 2.3 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 1.2 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.0 | 0.7 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 0.6 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) |
0.0 | 0.3 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.0 | 0.7 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.0 | 0.3 | GO:0030957 | Tat protein binding(GO:0030957) |
0.0 | 0.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.2 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.0 | 0.3 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.0 | 0.6 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 0.1 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.0 | 2.3 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.0 | 0.6 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 0.3 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.9 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.0 | 0.8 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.7 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.2 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.0 | 1.2 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 0.1 | GO:0035473 | lipase binding(GO:0035473) |
0.0 | 0.2 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.0 | 0.1 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
0.0 | 0.3 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.0 | 0.4 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 1.2 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 2.1 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.0 | 0.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 1.8 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 3.0 | GO:0017137 | Rab GTPase binding(GO:0017137) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 5.9 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 1.7 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 4.5 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 1.9 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 5.1 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.5 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.2 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 2.0 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.9 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.9 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.4 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 1.0 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 1.9 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 1.1 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 3.2 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.4 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 3.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.8 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.8 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 4.3 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 2.9 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 1.3 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.1 | 0.8 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 1.8 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 1.0 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 2.2 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.7 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.0 | 0.4 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.0 | 0.6 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.8 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 1.0 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.6 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 0.9 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.0 | 0.8 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 1.7 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 1.6 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.1 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.0 | 1.2 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.6 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.8 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 0.7 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 0.9 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 0.3 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.0 | 0.5 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.3 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.0 | 0.3 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 0.4 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.0 | 0.7 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |